Pharmaceutical regulatory law in New Zealand

Bell Gully has authored the New Zealand chapter in a publication which looks at antitrust laws and regulations in the pharmaceutical industry across 29 jurisdictions worldwide.

In 2008 the Global Competition Review published the first edition of Getting the Deal Through - Pharmaceutical Antitrust. Partner Phil Taylor and senior associate Torrin Crowther contribute a chapter on pharmaceutical regulatory law in New Zealand and examine how the law is enforced.

They review how mergers between pharmaceutical companies are controlled, what constitutes anti-competitive conduct and how authorities manage such conduct, along with legal trends and developments in the pharmaceutical area.

Click here to read the New Zealand chapter, reproduced with permission from Law Business Research.

This article was first published in Getting the Deal Through – Pharmaceutical Antitrust 2008, (published in April 2008 - contributing editor: Marleen Van Kerckhove). For further information please visit www.GettingTheDealThrough.com

For more information contact:

Phil Taylor
Partner

Torrin Crowther
Senior Associate

Enquiries and information

For more information on any of the cases, articles and features in Commercial Quarterly, please email Diane Graham or call her on 64 9 916 8849.